KIMIA KLINIK

REFERENSI RENTANG NILAI NORMAL

Analyte Reference Ranges Refe- Notes

rence
Group Conventional SI s

Alanine Amino 1d < 31 U/L

Transferase
(ALT/SGPT) 2–5 d < 49 U/L

6 d–6 mth < 56 U/L

7–12 mth 1d < 54 U/L < 31 U/L

1–3 yr < 33 U/L

4–6 yr 2–5 d < 29 U/L < 49 U/L

6 d–6 mth
7–12 yr < 39 U/L < 56 U/L

13–17 yr f7–12 mth < 24 U/L < 54 U/L

1–3 yr < 33 U/L

m < 25 U/L
4–6 yr < 29 U/L
1d <109 U/L
Aspartate amino-

Transferase 2–5 d <97 U/L

(AST/SGOT

6 d–6 mth <77 U/L

7–12 mth <82 U/L

1–3 yr <48 U/L

4–6 yr <36 U/L

KIMIA KLINIK

7–12 yr <47 U/L

13–17 yr f
<29 U/L
m <25 U/L

Bilirubin, total Neonates

(premature) < 10.5 mg/dL

Newborns (full term),

children 1d <7.0 mg/dL

3-7d < 12.0 mg/dL

Bilirubin, direct 0 days - 5 years 0.2 - 0.8 mg/dL

(conjugated) 5 years - 17 years 0.1 - 0.3 mg/dL

17 years - 100 years 0.1 - 0.3 mg/dL

Calcium, total Prematur 7.6 - 10.0 mg/dL

2 – 12 Month 8.4 - 10.8 mg/dL

1 -4 Years 8.4 – 10.4 mg/dL

5 – 20 Years 9.2 – 11.0 mg/dL

21 – 50 Years 8.8 – 10.2 mg/dL

> 50 Years 8.4 – 9.7 mg/dL

Calcium, 4.7–5.2 mg/dL

free, ionized

Chloride Prematur 97 - 122 mEq/L

1 Days – 4 Week 95 - 116 mEq/L

1 – 12 Month 93 - 112 mEq/L

>1 Years 96 - 111 mEq/L

KIMIA KLINIK

Adults >65 Years 98 - 106 mEq/L

Potassium Prematur 3.2 – 4.6 mEq/L

(Kalium)
1 Day – 4 Week 3.6 – 6.1 mEq/L

1 – 12 Month 3.6 – 5.8 mEq/L

> 1 Years 3.1 – 5.1 mEq/L

Adults >60 Years 3.7 – 5.4 mEq/L

Sodium(Natrium) Prematur 128 – 147 mEq/L

1 Day – 4 Week 132 – 147 mEq/L

1 – 12 Month 129 – 143 mEq/L

> 1 Years 132 – 145 mEq/L

Adults >60 Years 132 – 146 mEq/L

Cholesterol, total Prematur 32 – 76 mg/dL EDTA plasma yields 3 –6 % lower values

than serum.
< 4 Week 50 – 170 mg/dL

1 – 12 Month 60 – 170 mg/dL

> 1 Years 110 – 230 mg/dL

Adults > 17 Years

No risk < 200 mg/dL 46

Classification acc. to NCEP ATP III
Moderate risk 200 – 239 mg/dL
High risk > 239 mg/dL

Cholesterol, HDL Major risk ‡40 mg/dL <1.0 mmol/L 46 Classification acc. to NCEP ATP III
“Negative” risk <60 mg/dL <1.6 mmol/L
KIMIA KLINIK

No risk >1.68 mmol/L 220 European guidelines

f >65 mg/dL >1.45 mmol/L
m
>55 mg/dL

Moderate risk
1.15 – 1.68 mmol/L
f 0.9 – 1.45 mmol/L
45 – 65 mg/dL
m
35 - 55 mg/dL
High risk
<1.15 mmol/L
f 0.90 mmol/L
<45 mg/dL
m
<35 mg/dL

Cholesterol, LDL Adults <155 mg/dL <4.0 mmol/L 66

Adult levels Optimum <100 mg/dL <2.60 mmol/L 46 Classification acc. to NCEP ATP III

Near/above optimum 100–129 mg/dL 2.60–3.35 mmol/L

Borderline high 130–159 mg/dL 3.36–4.15 mmol/L

High 160–189 mg/dL 4.16–4.90 mmol/L

Very high >190 mg/dL >4.90 mmol/L

Low risk <100 mg/dL <2.6 mmol/L 217 Target values acc. to ATP III

Moderate risk <135 mg/dL <3.5 mmol/L

High risk >160 mg/dL >4.1 mmol/L

Creatinine Neonates, premature 0.5 – 1.2 mg/dL 220, 235 Jaffé method, Roche Diagnostics
Neonates, full term
0.4 – 0.7 mg/dL
Infant

Children 0.5 – 1.2 mg/dL

KIMIA KLINIK

Adults f 0.6 – 1.1 mg/dL <80 mmol/L 173, 220 Jaffé method, Roche Diagnostics

m 0.7 – 1.3 mg/dL <106 mmol/L

KIMIA KLINIK

Glucose Prematur 54–103 mg/dL

Neonatus > 6 Hours 40 - 60 mg/dL

> 5 Days 50 - 80 mg/dL

1 – 2 Years 33 – 111 mg/dL

3 – 4 Years 52 - 98 mg/dL

5 – 6 Years 69–100 mg/dL

Adults 60 - 100 mg/dL

Troponin I Adults 22–65 yr 0.16 ng/mL 0.16 mg/L 15 Chemiluminescence immunoassay

Neonates 0.183 ng/mL 0.183 mg/L 22 Enzyme immunoassay

Urea Prematur < 16 mg/dL 271

Neonatus < 42 mg/dL

≤ 6 Month < 42 mg/dL

> 6 Month < 48 mg/dL

Adults ≤ 65 Years < 50 mg/dL

>65 Years < 71mg/dL

Uric acid Prematur <5.5 mg/dL

1– 4 W e e k < 5.2 mg/dL

1 - 12 Month < 6.2 mg/dL

Children < 6.1 mg/dL

Adult W 2.5 - 6.8 mg/dL

M 3.6 – 7.7 mg/dL

eGFR Normal >90 mL/min/1.73m2

Penurunan ringan 60 - 89 mL/min/1.73m2

Penurunan sedang 30 - 59 mL/min/1.73m2

KIMIA KLINIK

Penurunan berat 15 - 29 mL/min/1.73m2

Gagal Ginjal < 15 mL/min/1.73m2

Serum Iron Neonatus 36 – 184 µg/dL

1 – 30 Days W 29 – 127 µg/dL
M 32 – 112 µg/dL
1 – 12 Month W 25 - 126 µg/dL
M 27 – 109 µg/dL
1 – 3 Years W 25 – 101 µg/dL
M 29 – 91 µg/dL
4 – 6 Years W 28 – 93 µg/dL
M 25 – 115 µg/dL
7 – 9 Years W 30 – 104 µg/dL
M 27 – 96 µg/dL
10 - 12 Years W 32 – 104 µg/dL
M 28 – 112 µg/dL
13 - 15 Years W 30 – 109 µg/dL
M 26 – 110 µg/dL
16 - 18 Years W 33 – 102 µg/dL
M 27 – 138 µg/dL
Adults W 37 – 145 µg/dL
M 59 – 158 µg/dL
IMUNOSEROLOGI

C-Reactive Protein < 10 mg/dL

(CRP)

High Sensitive Neonatus < 21d < 41 mg/dL

2 Month – 15 Years < 0.28 mg/dL
Adults < 0.50 mg/dL
W 50 – 64 years < 0.85 mg/dL
≥ 65 years <0.66 mg/dL
M 50 – 64 years < 0.79 mg/dL
≥ 65 years < 0.68 mg/dL

HbA1C 4.5 – 6.5 %

Ferritin Neonates 25 – 200 ng/mL

2 – 3 Month 80 – 500 ng/mL
4 Month – 16 Years 20 – 200 ng/mL
Adults w 20 – 250 ng/mL
m 30 – 350 ng/mL

Vitamin D 25- Deficiency < 10 ng/mL

Hydroxy Insufficiency 10 - 30 ng/mL
Sufficiency 30 - 100 ng/mL

Tubex-TF Negatif 0-2

Inconclusive 3 (Ulangi pengambilan sample pada hari berikutnya)
Positive 4 - 10

Thyroid Stimulating < 12 Month 1.36 – 8.8 µU/mL

Hormone (TSH) 1 – 6 Years 0.85 – 6.5 µU/mL
7 – 12 years 0.28 – 4.3 µU/mL
Adults 0.34 – 5.6 µU/mL

TSHs Neonatus Normal < 9 µIU/mL Flourescence Immunoassay

Borderline 6 – 18 µIU/mL
IMUNOSEROLOGI

Hypothyroid >18 µIU/mL

2 – 30 Days ≤ 20 µIU/mL

NS1 Negatif

IgG Dengue & IgM Non Reaktif

Dengue

PPD/Mantoux dibaca oleh dokter setelah 48 - 72 Jam

Rapid Test Antigen Negatif

PCR Negatif >40

Positif <40

Anti HIV Non Reaktif

HBsAg Non Reaktif

Syphilis Non Reaktif

Darah samar/Benzidine Negatif

T3 Triodotryronine 18 years - 100 years 0.8 - 2.0 ng/mL

16 years - 17 years m 0.71 - 2.12 ng/mL

f 0.61 - 1.51 ng/mL

11 years - 15 years m
0.8 - 2.33 ng/mL
f
0.6 - 2.09 ng/mL
1 years - 10 years
0.82 - 2.82 ng/mL

T4 Thyroxine Adult 57.9 - 150.6 µg/dL

Betta HCG Non Pregnant female <5

Kuantitatif Serum
1 - 10 weeks < 417.430
IMUNOSEROLOGI

11 - 15 week 16.996 - 247.465

16 - 22 weeks 6.860 - 50.239

23 - 40 weeks 1.583 - 65.911

HEMATOLOGI

Differential
leucocyte count

Band neutrophils Infants <8 %

Blood must be smeared within 3 hours (93)
Children 3–6 %
Adults 3–5 %

Segmented Infants 17–60 %

neutrophils Children 25–60 %
Adults 50–70 %

Eosinophils Infants 1–5 %

Children 1–5 %
Adults 2–4 %

Infants <1 %
Basophils
Children <1 %
Adults <1 %

Monocytes Infants 1–11 %

Children 1–6 %
Adults 2–8 %
Lymphocytes
Infants 20–70 %
Children 25–50 %
Adults 25–40 %

Hematocrit 1d 44–72 %
(Hct, PCV)
2–6 d 50–82 %

14–23 d 42–62 %

24–37 d 31–59 %

40–50 d 30–54 %
HEMATOLOGI

2–2.5 mth 30–46 %

3 -3.5 mth 31–43 %

5–7 mth 32–44 %

8 mth–3 yr 35–43 %

5 yr 31–43 %

10 yr 33–45 %

Adults f 35–47 %

m 40–52 %

Hemoglobin (Hb) 1d 15.2–23.6 g/dL

in blood
2–6 d 15.0–24.6 g/dL

14–23 d 12.7–18.7 g/dL

24–37 d 10.3–17.9 g/dL

40–50 d 9.0–16.6 g/dL

2–2.5 mth 9.2–13.6 g/dL

3–3.5 mth 9.6–12.8 g/dL

5–7 mth 10.1–12.9 g/dL

8–10 mth 10.5–12.9 g/dL

11 –13.5 mth 10.7–13.1 g/dL

1.5–3 yr 10.8–12. 8 g/dL

5 yr 10.7–14.7 g/dL
10 yr 10.8–15.6 g/dL

Adults f 12.3–15.3 g/dL

m 14.0–17.5 g/dL
HEMATOLOGI

>70 yr f 11.7–16.2 g/dL

m 12.1–17.6 g/dL
>75 yr f 11.6–16.1 g/dL
m 11.8–17.5 g/dL
>81 yr f 10.9–15.5 g/dL
m 11.6–16.3 g/dL

Leucocytes 12 h 13,000–38,000/µL
1d 9,400–34,000/ µL
1w 5,000–21,000/ µL
2w 5,000–20,000/ µL
4w 5,000–19,500/ µL
2 mth 5,500–18,000/ µL
4–12 mth 6,000–17,500/ µL
2 yr 6,000–17,000/ µL
4 yr 5,500–15,500/ µL
6 yr 5,000–14,500/ µL
8–12 yr 4,500–13,500/ µL
14–16 yr 4,500–13,000/ µL
18 yr 4,500–12,500/ µL
20 yr 4,500–11,500/ µL

Adults 4,400–11,300/ µL

MCH (Hb/RBC) 1d 33–41 pg/cell

2–6 d 29–45 pg/cell
14–37 d 26–38 pg/cell
40–50 d 25–37 pg/cell
HEMATOLOGI

2–2.5 mth 24–36 pg/cell

3–3.5 mth 23–36 pg/cell
5–10 mth 21–33 pg/cell
11 mth–5 yr 23–31 pg/cell
10 yr 22–34 pg/cell

Adults 28–33 pg/cell

MCHC 1d 31 –35 g/dL

2–6 d 24 –36 g/dL
14–23 d 26 –34 g/dL
24–37 d 25 –37 g/dL
40 d–7 mth 26 –34 g/dL
8–13.5 mth 28 –32 g/dL
1.5–3 yr 26 –34 g/dL
5–10 yr 32 –36 g/dL

Adults 33 –36 g/dL

MCV 1d 98–122 µm3

2–6 d 94–150 µm3
14–23 d 84–128 µm3
24–37 d 82–126 µm3
40 – 50 d 81–125 µm3
2–2.5 mth 81–121 µm3
3–3.5 mth 77–113 µm3
5–7 mth 73–109 µm3
8–10 mth 74–106 µm3
11 –13.5 mth 74–102 µm3
HEMATOLOGI

1.5–3 yr 73–101 µm3

5 yr 72–88 µm3
10 yr 69–93 µm3

Adults 80–96 µm3

Thrombocytes 1–5 yr f 229 –553 q 103/mL

m 217 –497 q 103/mL
6–10 yr f 184 –488 q 103/mL
m 181 –521 q 103/mL
11–15 yr f 154 –442 q 103/mL
m 156 –408 q 103/mL
16–20 yr f 154 –386 q 103/mL
m 140 –392 q 103/mL
21–30 yr f 154 –386 q 103/mL
m 140 –336 q 103/mL
31–40 yr f 170 –394 q 103/mL
m 132 –356 q 103/mL

41–50 yr f 149 –409 q 103/mL

m 139 –403 q 103/mL

51–60 yr f 177 –393 q 103/mL

m 136 –380 q 103/mL

152 –396 q 103/mL
61–70 yr f
150 –362 q 103/mL
m
149 –409 q 103/mL
>70 yr f
139 –335 q 103/mL
m

RBC 1d 4.3 – 6.3 mil/µL

2–6 d 4.0 – 6.8 mil/µL
HEMATOLOGI

14–23 d 3.7 – 6.1 mil/µL

24–37 d 3.2 – 5.6 mil/µL
40 – 50 d 3.1 – 5.1 mil/µL
2–2.5 mth 2.8 – 4.8 mil/µL
3–3.5 mth 3.1 – 4.7 mil/µL
5–7 mth 3.2 – 5.2 mil/µL
8 mth –3 year 3.6 – 5.2 mil/µL
5 yr 3.6 – 5.2 mil/µL
10 yr 3.8 – 5.8 mil/µL
Adults
F 4.1 – 5.1 mil/µL
M 4.5 – 5.9 mil/µL

Adults W < 20
M < 10
LED
KOAGULASI

Reference Ranges Refe- Notes

Analyte rences
Group Conventional SI

D-Dimer 1–6 yr < 0.6 mg/mL < 0.6 mg/L 216 ELISA

7–12 yr < 0.5 mg/mL < 0.5 mg/L

13–18 yr < 0.7 mg/mL < 0.7 mg/L

Pregnancy <20 w <2.2 mg/mL <2.2 mg/L

180
21–40 w <4.3 mg/mL <4.3mg/L

Adults <0.5 mg/mL <0.5 mg/L

220
<0.5 mg/mL < 0.5 mg/L Enzyme immunoassay
220
Immunoturbidimetric assays, Roche
CARDIAC D-Dimer

Prothrombin time 11 – 18 sec

(PT)

International
normalized ratio 0.85 – 1.15 sec
(INR)

Activated Partial 27 – 42 sec

Thromboplastin
Time (APTT)
URINALISIS

Analyte Reference Ranges Refe- Notes

rences
Group Conventional SI

Bacteria Children 3
<10 /mL <109/L 220 Chamber count
Adults
5
<10 /mL 11
<10 /L

Specific gravity Neonates, 1.012 g/mL

1.002–1.006 g/mL
first few days 1.012 220 Daily urine, normal diet
after first few
days 1.015–1.025 g/mL 1.002–1.006

Adults 1.015–1.025

Urinary sediment

Erythrocytes 0 –1 per field (<5/mL) 0–1 per field (<5 Mpt/L) 215 Group classification per field

Leucocytes 1–2 per field (<10/mL) 1–2 per field (<10 Mpt/L) (magnification q 400):

Squamous Not detectable

epithelial cells 0 - 2 per field 0 – 2 per field 0–1

Renal epithelial cells Not detectable Not detectable 1–4

Casts 5–15

hyaline Only occasional Only occasional 15–50

epithelial Not detectable Not detectable > 50

erythrocyte Not detectable Not detectable Crowding

granulated Not detectable Not detectable

leucocyte Not detectable Not detectable

Bacteria Not detectable Not detectable Group classification per field

Yeast cells Not detectable Not detectable (magnification q 400):

Trichomonads Not detectable Not detectable Not detectable

Lampiran :
Nomor :
Tentang : Penetapan Nilai Kritis Laboratorium
1. Pemeriksaan Hematologi

N Parameter Nilai Kritis Nilai Kritis

o Rendah Tinggi

1 Hemoglobin < 7 g/dL >18g/dL

2 Hemoglobin Neonatus <8.5 g/dL >23g/dL

3 Hemoglobin Ibu Hamil < 8 g/dL

4 Hematokrit < 20 % >60%

5 Hematokrit Neonatus < 33 % >70%

6 Leukosit < 2000/mm3 >40.000/mm3

 7 Leukosit Neonatus >50.000/mm3

8 Trombosit < 50.000/mm3 >1.000.000/mm3

9 Trombosit Neonatus < 30.000/mm3 >1.000.000/mm3

10 Trombosit Pasien Keganasan < 10.000/mm3

11 INR >3

12 APTT >90 det

13 APTT Neonatus >240 det

14 Fibrinogen < 50 mg/dL

15 Protombin Time (PT) >110det

Nilai Kritis Hemoglobin tidak dilaporkan pada pasien Thalasemia dan Gagal Ginjal Kronis(Hemodialisis) di
Poli/Rawat Jalan

2. Pemeriksaan Kimia Klinik

N Parameter Nilai Kritis Nilai Kritis

o Rendah Tinggi

1 Glukosa < 7 g/dL >18g/dL

2 Glukosa Neonatus < 47 mg/dL >540mg/dL

 3 Natrium <120 mmol/dL >160 mmol/dL

4 Kalium <2.8 mmol/dL >6 mmol/dL

5 Kalium Neonatus/CKD >7mmol/dL

6 Ureum < 2mg/dL >100mg/dL

7 Ureum Neonatus >56mg/dL

8 Kreatinin >5mg/dL

9 Kreatinin Neonatus >5.65mg/dL

10 Magnesium < 1.8mg/dL >5mg/dL

11 Magnesium Neonatus >9.73mg/dL

12 Bilirubin >15mg/dL

13 Bilirubin Neonatus >15mg/dL

3. Imunoserologi ( HIV,HbsAg, Syphilis, Antigen) Langsung Lapor